A. Mattsson

发表

Improvements in Body Composition after 4 Years of Growth Hormone Treatment in Adult-Onset Hypopituitarism Compared to Age-Matched Controls

A. V. van Beek, M. Drent, M. Postma, 2019, Neuroendocrinology.

Healthcare utilization, quality of life and patient-reported outcomes during two years of GH replacement therapy in GH-deficient adults--comparison between Sweden, The Netherlands and Germany.

J. Svensson, M. Kołtowska-Häggström, H. Koppeschaar, 2006, European journal of endocrinology.

Growth hormone (GH) replacement therapy in GH deficient adults: predictors of one-year metabolic and clinical response.

J. Svensson, P. Harris, M. Kołtowska-Häggström, 2007, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

New Neoplasm During GH Replacement in Adults With Pituitary Deficiency Following Malignancy: A KIMS Analysis

A. Luger, R. Abs, D. Maiter, 2017, Journal of Clinical Endocrinology and Metabolism.

Proposal of a clinical response score and predictors of clinical response to 2 years of GH replacement therapy in adult GH deficiency.

H. Wallaschofski, M. Buchfelder, H. Schneider, 2015, European journal of endocrinology.

Change in baseline characteristics over 20 years of adults with growth hormone (GH) deficiency on GH replacement therapy.

U. Feldt-Rasmussen, P. Burman, C. Høybye, 2019, European journal of endocrinology.

Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis.

M. Thunander, M. Kołtowska-Häggström, A. Luger, 2013, European journal of endocrinology.

Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA): Comparison of Normative Reference Data for the General Population of England and Wales with Results for Adult Hypopituitary Patients with Growth Hormone Deficiency

P. Kind, M. Kołtowska-Häggström, A. Mattsson, 2005, Hormone Research in Paediatrics.

The relationship between glucocorticoid replacement and quality of life in 2737 hypopituitary patients.

M. Kołtowska-Häggström, G. Johannsson, O. Ragnarsson, 2014, European journal of endocrinology.

Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.

M. Kołtowska-Häggström, B. Bengtsson, U. Feldt-Rasmussen, 2006, European journal of endocrinology.

ALL-CAUSE MORTALITY IN PATIENTS WITH ACROMEGALY TREATED WITH PEGVISOMANT AN ACROSTUDY ANALYSIS.

A. Klibanski, N. Tritos, B. Biller, 2020, European journal of endocrinology.

Pregnancy outcomes in women with growth hormone deficiency.

A. Luger, B. Biller, M. Riedl, 2015, Fertility and sterility.

Registries as a tool in evidence‐based medicine: example of KIMS (Pfizer International Metabolic Database)

M. Kołtowska-Häggström, A. Luger, P. Jönsson, 2008, Pharmacoepidemiology and drug safety.

Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life?

P. Kind, X. Badia, F. Casanueva, 2006, European journal of endocrinology.

Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysis.

M. Korbonits, A. Klibanski, G. Johannsson, 2014, The Journal of clinical endocrinology and metabolism.

Serum Insulin-Like Growth Factor I Reference Values for an Automated Chemiluminescence Immunoassay System: Results from a Multicenter Study

G. Brabant, L. Wilhelmsen, M. Ranke, 2003, Hormone Research in Paediatrics.

Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.

M. Ranke, K. Osterziel, A. Mattsson, 2008, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis.

M. Thunander, M. Kołtowska-Häggström, A. Luger, 2011, European journal of endocrinology.

The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients.

M. Kołtowska-Häggström, G. Johannsson, A. Mattsson, 2006, The Journal of clinical endocrinology and metabolism.

Radiotherapy, Especially at Young Age, Increases the Risk for De Novo Brain Tumors in Patients Treated for Pituitary/Sellar Lesions

A. V. van Beek, B. Biller, P. Burman, 2017, The Journal of clinical endocrinology and metabolism.

Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.

M. Kołtowska-Häggström, B. Bengtsson, U. Feldt-Rasmussen, 2005, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality.

P. Dahlqvist, J. Svensson, G. Johannsson, 2013, The Journal of clinical endocrinology and metabolism.

Overall and cause-specific mortality in GH-deficient adults on GH replacement.

M. Kołtowska-Häggström, B. Bengtsson, U. Feldt-Rasmussen, 2012, European journal of endocrinology.

GH deficiency after traumatic brain injury: improvement in quality of life with GH therapy: analysis of the KIMS database.

M. Korbonits, D. Cuthbertson, C. Daousi, 2015, European journal of endocrinology.

Assessment of quality of life in adult patients with GH deficiency: KIMS contribution to clinical practice and pharmacoeconomic evaluations.

M. Kołtowska-Häggström, S. Shalet, A. Mattsson, 2009, European journal of endocrinology.

Growth hormone treatment in children is not associated with an increase in the incidence of cancer: experience from KIGS (Pfizer International Growth Database).

F. Darendeliler, A. Mattsson, P. Wilton, 2010, The Journal of pediatrics.

Increasing frequency of combination medical therapy in the treatment of acromegaly with the GH receptor antagonist pegvisomant

C. Strasburger, B. Biller, A. Mattsson, 2018, European journal of endocrinology.

Incidence of Diabetes Mellitus and Evolution of Glucose Parameters in Growth Hormone–Deficient Subjects During Growth Hormone Replacement Therapy

M. Thunander, A. Luger, R. Abs, 2011, Diabetes Care.

Total and cause-specific mortality in patients from the KIMS database: direct evidence for a beneficial effect of GH replacement therapy on mortality in adult GH deficient patients

M. Kołtowska-Häggström, A. Mattsson, P. Wilton, 2008 .

Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15 809 GH-Treated Patients

M. Korbonits, A. V. van Beek, P. Touraine, 2022, The Journal of clinical endocrinology and metabolism.

Comparative effectiveness of bisoprolol and metoprolol succinate in patients with heart failure.

H. Svanström, B. Pasternak, A. Hviid, 2015, International Journal of Cardiology.

Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption.

J. Svensson, B. Bengtsson, T. Rosén, 2004, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

The prevalence of the metabolic syndrome and associated cardiovascular complications in adult-onset GHD during GH replacement: a KIMS analysis

A. Luger, R. Abs, A. Mattsson, 2018, Endocrine connections.

Relative Risks of Contributing Factors to Morbidity and Mortality in Adults With Craniopharyngioma on Growth Hormone Replacement

M. Geffner, K. Yuen, E. Erfurth, 2018, The Journal of clinical endocrinology and metabolism.

Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database).

M. Ranke, M. Kołtowska-Häggström, V. Popović, 2010, The Journal of clinical endocrinology and metabolism.

Healthcare utilization, quality of life and patient-reported outcomes during two years of GH replacement therapy in GH-deficient adults--comparison between Sweden, The Netherlands and Germany.

J. Svensson, H. Koppeschaar, P. Kann, 2006, European journal of endocrinology.

Overall and cause-specific mortality in GH-deficient adults on GH replacement.

B. Bengtsson, U. Feldt-Rasmussen, R. Abs, 2012, European journal of endocrinology.